Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy

Toshiaki Yoshikawa, Zhiwen Wu, Satoshi Inoue, Hitomi Kasuya, Hirokazu Matsushita, Yusuke Takahashi, Hiroaki Kuroda, Waki Hosoda, Shiro Suzuki, Yuki Kagoya

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds